SCHEMBL6505895

SCHEMBL6505895

O=C=NC(Cl)(Cl)CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29033860 0.74
SCHEMBL29033863 0.72
SCHEMBL11219724 0.69
SCHEMBL3783424 0.69
SCHEMBL333647 0.68
SCHEMBL1019166 0.67
SCHEMBL28175944 0.67
SCHEMBL11219433 0.66
Hydrochloric Acid SCHEMBL5440442 0.65
SCHEMBL11811940 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118139627-A Conjugates, compositions and methods for rejuvenating CAR T cells 普渡研究基金会 2024-06-04 CN disclosed
US-20050009843-A1 Medicine for inhibiting drug elimination pump TRINE PHARMACEUTICALS, INC. 2005-01-13 US disclosed
EP-1389463-A1 MEDICINE FOR INHIBITING DRUG ELIMINATION PUMP DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-02-18 EP disclosed
US-4411752-A Preparation of 1-monochloroethylcarbamyl chloride BASF AKTIENGESELLSCHAFT (DE) 1983-10-25 US disclosed
US-4310459-A Process for producing carbamoyl substituted penams and carbamoyl substituted cephams from penicillin sulfoxide esters BRISTOL-MYERS COMPANY (US) 1982-01-12 US disclosed